Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial

Published:2015-08 Issue:9992 Volume:386 Page:433-443
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Gnant Michael,Pfeiler Georg,Dubsky Peter C,Hubalek Michael,Greil Richard,Jakesz Raimund,Wette Viktor,Balic Marija,Haslbauer Ferdinand,Melbinger Elisabeth,Bjelic-Radisic Vesna,Artner-Matuschek Silvia,Fitzal Florian,Marth Christian,Sevelda Paul,Mlineritsch Brigitte,Steger Günther G,Manfreda Diether,Exner Ruth,Egle Daniel,Bergh Jonas,Kainberger Franz,Talbot Susan,Warner Douglas,Fesl Christian,Singer Christian F

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Tailoring therapies—improving the management of early breast cancer: St Gallen International Experts Consensus on the Primary Therapy of Early Breast Cancer 2015;Coates;Ann Oncol,2015

2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial;Forbes;Lancet Oncol,2008

3. Systematic review of bone health in older women treated with aromatase inhibitors for early-stage breast cancer;Becker;J Am Geriatr Soc,2012

4. Increased fracture rate in women with breast cancer: a review of the hidden risk;Body;BMC Cancer,2011

5. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy;Gnant;Lancet Oncol,2008

Cited by 458 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone complications of cancer treatment;Cancer Treatment Reviews;2024-11

2. Drug repurposing: Clinical practices and regulatory pathways;Perspectives in Clinical Research;2024-09-10

3. Cancer treatment-induced bone loss;The Korean Journal of Internal Medicine;2024-09-01

4. Effect of bisphosphonate and denosumab treatment on TBS in Japanese breast cancer patients with AIBL;Journal of Bone and Mineral Metabolism;2024-08-13

5. Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates;Internal and Emergency Medicine;2024-08-02